Delphi Management Partners VIII »

Mereo Biopharma Group Plc ads shares owned by Delphi Management Partners VIII

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by Delphi Management Partners VIII from 13F filings

Historical chart of Delphi Management Partners VIII investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by Delphi Management Partners VIII consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by Delphi Management Partners VIII

Quarter filed Position value Share count Share price at filing
2021-09-30 $621k 257k 2.42
2021-06-30 $814k 257k 3.17
2021-03-31 $865k 257k 3.37
2020-12-31 $919k 257k 3.58
2019-12-31 $842k 257k 3.28

More positions owned by Delphi Management Partners VIII

Tandem Diabetes Common Stock (TNDM)
Karyopharm Therapeutics Common Stock (KPTI)
Calithera Biosciences Common Stock
Mereo BioPharma Group Ads (MREO)

View all positions for Delphi Management Partners VIII

Top funds holding Mereo Biopharma Group Plc ads

Soleus Capital Management
683 Capital Management
Tejara Capital
Clearline Capital
Goldman Sachs Group
Standard Life Aberdeen
Millennium Management
DAFNA Capital Management
Monaco Asset Management SAM
Citadel Advisors
Toroso Investments
Two Sigma Investments
Squarepoint Ops
J. Goldman & Co
Knoll Capital Management

View all funds holding Mereo Biopharma Group Plc ads